124 related articles for article (PubMed ID: 187620)
21. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
22. Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region.
Maruyama T; Mitsui H; Maekawa H; Yamada H; Hirayama M; Iino S; Yasuda K; Koike K; Kimura S; Milich DR
Am J Gastroenterol; 2000 Oct; 95(10):2894-904. PubMed ID: 11051365
[TBL] [Abstract][Full Text] [Related]
23. Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations.
Pozsonyi T; Fehér J; Jakab L
Allergol Immunopathol (Madr); 1981; 9(1):37-44. PubMed ID: 6973266
[TBL] [Abstract][Full Text] [Related]
24. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.
Hara S; Hoshino Y; Naitou T; Nagano K; Iwai M; Suzuki K; Yamamoto K; Nagasaka T; Morishima T; Kimura H
J Clin Virol; 2006 Mar; 35(3):250-6. PubMed ID: 16181807
[TBL] [Abstract][Full Text] [Related]
25. Alterations in helper-specific circulating T lymphocytes and in the autologous mixed lymphocyte reaction in chronic hepatitis B.
Mazzetti M; Stefanini GF; Mazzeo V; Baraldini M; Canonica GW; Marini E; Miglio F; Gasbarrini G; Lee WM
Am J Gastroenterol; 1987 Feb; 82(2):130-4. PubMed ID: 2949600
[TBL] [Abstract][Full Text] [Related]
26. Lymphocytotoxins in acute and chronic hepatitis. Characterization and relationship to changes in circulating T lymphocytes.
Dehoratius RJ; Henderson C; Strickland RG
Clin Exp Immunol; 1976 Oct; 26(1):21-7. PubMed ID: 1087213
[TBL] [Abstract][Full Text] [Related]
27. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.
Tseng CT; Miskovsky E; Houghton M; Klimpel GR
Hepatology; 2001 May; 33(5):1312-20. PubMed ID: 11343261
[TBL] [Abstract][Full Text] [Related]
28. Lymphocyte E rosette inhibitory factor: a regulatory serum lipoprotein.
Chisari FV; Edgington TS
J Exp Med; 1975 Nov; 142(5):1092-1107. PubMed ID: 172585
[TBL] [Abstract][Full Text] [Related]
29. [Serum inhibition factor in acute viral hepatitis].
Berg PA; Brattig N
Leber Magen Darm; 1984 Nov; 14(6):261-9. PubMed ID: 6334798
[TBL] [Abstract][Full Text] [Related]
30. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
Brunetto MR; Oliveri F; Colombatto P; Bonino F
Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic CD4 T cells in viral hepatitis.
Aslan N; Yurdaydin C; Wiegand J; Greten T; Ciner A; Meyer MF; Heiken H; Kuhlmann B; Kaiser T; Bozkaya H; Tillmann HL; Bozdayi AM; Manns MP; Wedemeyer H
J Viral Hepat; 2006 Aug; 13(8):505-14. PubMed ID: 16901280
[TBL] [Abstract][Full Text] [Related]
32. Treatment of chronic hepatitis B virus infection via oral immune regulation toward hepatitis B virus proteins.
Safadi R; Israeli E; Papo O; Shibolet O; Melhem A; Bloch A; Rowe M; Alper R; Klein A; Hemed N; Segol O; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Am J Gastroenterol; 2003 Nov; 98(11):2505-15. PubMed ID: 14638356
[TBL] [Abstract][Full Text] [Related]
33. [Immune response to HBsAg, HBcAg and e-antigen in patients with acute hepatitis and HBsAg carriers with and without liver diseases].
Meyer zum Büschenfelde KH; Arnold W; Knolle J; Hess G
Z Gastroenterol; 1976 May; 14(3):365-77. PubMed ID: 969780
[TBL] [Abstract][Full Text] [Related]
34. [Altered immunoregulation in chronic viral hepatitis. Deficiency of T-lymphocytes with membrane receptors for histamine].
Roffi L; Rumi MG; Cambieri R; Chinea B; Rossi A; Grossi C; Colombo M
Minerva Med; 1983 Oct; 74(39):2277-85. PubMed ID: 6197681
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen.
Murakami Y; Minami M; Daimon Y; Okanoue T
J Med Virol; 2004 Feb; 72(2):203-14. PubMed ID: 14695661
[TBL] [Abstract][Full Text] [Related]
36. Immunosuppressive serum factors in viral hepatitis. III. Prognostic relevance of rosette inhibitory factor and serum inhibition factor in acute and chronic hepatitis.
Grauer W; Brattig NW; Schomerus H; Frösner G; Berg PA
Hepatology; 1984; 4(1):15-9. PubMed ID: 6693065
[TBL] [Abstract][Full Text] [Related]
37. Evidence for spontaneous immunosuppression in autoimmune hepatitis.
Lohse AW; Kögel M; Meyer zum Büschenfelde KH
Hepatology; 1995 Aug; 22(2):381-8. PubMed ID: 7635404
[TBL] [Abstract][Full Text] [Related]
38. [Liver cell membrane autoantibody (LMA) in chronic liver disease].
Garagnani M; Meliconi R; Mazzoli M; Stancari V; Mariani AR; Morabito F; Miglio F; Facchini A
Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1585-9. PubMed ID: 7459079
[TBL] [Abstract][Full Text] [Related]
39. Species cross-reactivity of anti-LSP antibodies in acute viral hepatitis.
Perperas A; McFarlane BM; McSorley CG; McFarlane IG; Williams R
J Clin Lab Immunol; 1986 Jan; 19(1):25-30. PubMed ID: 2422379
[TBL] [Abstract][Full Text] [Related]
40. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver.
Bengsch B; Spangenberg HC; Kersting N; Neumann-Haefelin C; Panther E; von Weizsäcker F; Blum HE; Pircher H; Thimme R
J Virol; 2007 Jan; 81(2):945-53. PubMed ID: 17079288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
